Sequence engineering to improve the syringeability of high concentration monoclonal antibody formulations

Original language	English
Publication status	Published - 16 Aug 2023
Event	15th Annual Bioprocessing Summit - USA, Boston, United States Duration: 14 Aug 2023 → 17 Aug 2023 https://www.bioprocessingsummit.com/

Conference

Conference	15th Annual Bioprocessing Summit
Country/Territory	United States
City	Boston
Period	14/08/23 → 17/08/23
Internet address	https://www.bioprocessingsummit.com/

Keywords

• biologics
• antibody
• manufacture
• developability

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

• 
• 

Projects

• 1 Finished

Projects per year

• Sequence engineering to improve the performance of biopharma in patient administration syringe devices

  Rattray, Z. (Principal Investigator), Jamieson, C. (Principal Investigator) & Armstrong, G. (Post Grad Student)

  1/10/21 → 30/09/24

  Project: Research - Studentship

  • Immunoglobulin G 100%
  • Intravenous Immunoglobulin 50%
  • Immunoglobulin G3 50%
  • Monoclonal Antibody 46%
  • Solution and Solubility 16%

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Armstrong, G., Lewis, W., & Rattray, Z. (2023). Sequence engineering to improve the syringeability of high concentration monoclonal antibody formulations. 15th Annual Bioprocessing Summit, Boston, United States.

Armstrong, Georgina ; Lewis, Will ; Rattray, Zahra. / Sequence engineering to improve the syringeability of high concentration monoclonal antibody formulations. 15th Annual Bioprocessing Summit, Boston, United States.

@conference{c660d54bccb847f8a69609c248e7bf68,

title = "Sequence engineering to improve the syringeability of high concentration monoclonal antibody formulations",

keywords = "biologics, antibody, manufacture, developability",

author = "Georgina Armstrong and Will Lewis and Zahra Rattray",

year = "2023",

month = aug,

day = "16",

language = "English",

note = "15th Annual Bioprocessing Summit ; Conference date: 14-08-2023 Through 17-08-2023",

url = "https://www.bioprocessingsummit.com/",

}

Armstrong, G, Lewis, W & Rattray, Z 2023, 'Sequence engineering to improve the syringeability of high concentration monoclonal antibody formulations', 15th Annual Bioprocessing Summit, Boston, United States, 14/08/23 - 17/08/23.

Sequence engineering to improve the syringeability of high concentration monoclonal antibody formulations. / Armstrong, Georgina; Lewis, Will; Rattray, Zahra.
2023. 15th Annual Bioprocessing Summit, Boston, United States.

Research output: Contribution to conference › Presentation/Speech

TY - CONF

T1 - Sequence engineering to improve the syringeability of high concentration monoclonal antibody formulations

AU - Armstrong, Georgina

AU - Lewis, Will

AU - Rattray, Zahra

PY - 2023/8/16

Y1 - 2023/8/16

KW - biologics

KW - antibody

KW - manufacture

KW - developability

M3 - Presentation/Speech

T2 - 15th Annual Bioprocessing Summit

Y2 - 14 August 2023 through 17 August 2023

ER -

Armstrong G, Lewis W, Rattray Z. Sequence engineering to improve the syringeability of high concentration monoclonal antibody formulations. 2023. 15th Annual Bioprocessing Summit, Boston, United States.